据港交所1月3日披露,福建海西新药创制股份有限公司(以下简称:海西新药)递表港交所主板,华泰国际和招银国际为联席保荐人。
本文源自:金融界AI电报
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.